Company Profile

EarLens Corporation
Profile last edited on: 5/18/21      CAGE: 481B8      UEI: VW6KQLZ66V75

Business Identifier: Specialized hearing aid devices
Year Founded
2005
First Award
2006
Latest Award
2013
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

4045-A Campbell Avenue
Menlo Park, CA 94025
   (650) 366-9000
   info@earlenscorp.com
   www.earlenscorp.com
Location: Single
Congr. District: 18
County: San Mateo

Public Profile

Structured around providing hearing-impaired patients a hearing solution that surpassses current standard of care for sound performance, EarLens Corporation has developed a nonsurgical lens that directly vibrates the eardrum. Effectively, the device serves to deliver an ultra wide frequency range and achived higher maximum gain margin. Traditional hearing aids are basically tiny speakers that simply turn up the volume on air conducted sound. The EarLens Contact Hearing Device™ instead uses light to transmit sound. “Hear the Light™” The EarLens System is comprised of two components: a light-based Behind The Ear (BTE) sound processor, and a removable, custom-made Tympanic Contact Actuator (TCA) placed at the base of the ear canal. The BTE uses a microphone and a digital signal processor to pick up sound and convert it to infrared light. The EarLens Contact Hearing Device is designed to transform the user’s own eardrum into a speaker, which enables delivery of an ultra-wide frequency range (from 125 to 10,000 Hz) and a higher maximum gain margin. “A Full Spectrum of Sound™” Currently available only for investigational use . the EarLens systems is not marketed for sale. The company will be seeking FDA 510(k) clearance for the treatment of hear

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
100-149
Revenue Range
10M-15M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
25-49

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2013 2 NIH $2,393,914
Project Title: Wide-bandwidth open canal hearing aid for better multitalker speech understanding

Key People / Management

  William M Facteau -- Chairman, President & Ceo

  Rodney C Perkins -- Founder & Chief Medical Officer. CEO

  Mark Bishop -- Vice President Of Operations And Quality

  Brent Edwards -- Chief Technology Officer

  Jonathan Fay -- Founder

  George Harter -- Cfo

  Kenneth Mejia -- Director, R&D

  Ketan Muni -- Senior R&D Director

  Sunil Puria -- Founder and Chief Scientist

  Cem Shaquer -- Senior Vice President Of R&D

  John Winstead -- Founder

Company News

There are no news available.